Discontinued — last reported Q1 '26
Merck & Co. Animal Health — Income Before Taxes increased by 83.7% to $722.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 13.9%, from $634.00M to $722.00M. Over 4 years (FY 2021 to FY 2025), Animal Health — Income Before Taxes shows relatively stable performance with a 2.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates improved operational profitability, higher sales volume, or better cost management within the animal health division. A decrease suggests margin compression, rising operating expenses, or declining market demand for veterinary products.
This metric represents the total operating profit generated by the Animal Health business segment before the deduction o...
Comparable to segment-level operating income reported by other global life sciences or veterinary pharmaceutical companies.
mrk_segment_animal_health_income_before_taxes| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $552.00M | $505.00M | $321.00M | $585.00M | $571.00M | $515.00M | $292.00M | $566.00M | $467.00M | $421.00M | $283.00M | $555.00M | $508.00M | $510.00M | $365.00M | $634.00M | $593.00M | $511.00M | $393.00M | $722.00M |
| QoQ Change | — | -8.5% | -36.4% | +82.2% | -2.4% | -9.8% | -43.3% | +93.8% | -17.5% | -9.9% | -32.8% | +96.1% | -8.5% | +0.4% | -28.4% | +73.7% | -6.5% | -13.8% | -23.1% | +83.7% |
| YoY Change | — | — | — | — | +3.4% | +2.0% | -9.0% | -3.2% | -18.2% | -18.3% | -3.1% | -1.9% | +8.8% | +21.1% | +29.0% | +14.2% | +16.7% | +0.2% | +7.7% | +13.9% |